Note: Ingredients listed on restricted chemical lists
EC/CAS
9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
>=30-<50
EC/CAS
202-966-0/101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
>=20-<30 >=5% >=5% >=5% >=0,1%
EC/CAS
287-477-0/85535-85-9
Name of the chemical
Alkanes, C14-17, chloro
Concentration
>=10-<20 602-095-
EC/CAS
204-065-8/111-46-6
Name of the chemical
Diethylene glycol (DEG); 2,2′-oxydiethanol for traces level, see Annex III
Concentration
>=1-<10
EC/CAS
237-158-7/556-67-2
Name of the chemical
D4
Concentration
>=0,0025-<
EC/CAS
203-872-2
Name of the chemical
Diethylene glycol (DEG); 2,2′-oxydiethanol for traces level, see Annex III
Concentration
>=1-<10
EC/CAS
209-136-7
Name of the chemical
Octamethylcyclotetrasiloxane
Concentration
>=0,0025-<
General Information
Version
10.0
Revision date
2021-10-08
Product name
PU P/APLICACAO COM PISTOLA
1.2.1 Relevant identified uses
Construction material Professional use product
Emergency telephone
+351 219 157 200, +351 219 151 331, +351 800 250 250
Icons in SDS
Company Information
company name
Würth-Portugal Técnica de Montagem, Lda
e-mail address of the competent person responsible for the Safety Data Sheet
prodsafe@wuerth.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H222, H229, H315, H317, H319, H332, H334, H335, H351, H362, H373, H413
Hazard statements
Code
Statements
H222
Extremely flammable aerosol
H229
Pressurized container: may burst if heated
H315
Causes skin irritation
H317
May cause an allergic skin reaction
H319
Causes serious eye irritation
H332
Harmful if inhaled
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335
May cause respiratory irritation
H351
Suspected of causing cancer
H362
May cause harm to breast-fed children
H373
May cause damage to organs through prolonged or repeated exposure
H413
May cause long lasting harmful effects to aquatic life
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Danger
Hazard statements
H222 Extremely flammable aerosol. H229 Pressurised container: May burst if heated. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H332 Harmful if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. H351 Suspected of causing cancer. H362 May cause harm to breast-fed children. H373 May cause damage to organs through prolonged or repeated exposure. H413 May cause long lasting harmful effects to aquatic life.
Prevention
P201 Obtain special instructions before use. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P211 Do not spray on an open flame or other ignition source. P251 Do not pierce or burn, even after use. P260 Do not breathe spray. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P410 + P412 Protect from sunlight. Do not expose to tem- peratures exceeding 50 °C/ 122 °F.
Hazardous Ingredients
Diphenylmethane diisocyanate, isomers and homologues 4,4'-Diphenylmethane diisocyanate alkanes, C14-17, chloro
Additional information
"As from 24 August 2023 adequate training is required before industrial or pro- fessional use."
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Excessive exposure may aggravate preexisting asthma and other respiratory disorders (e.g. em- physema, bronchitis, reactive airways dysfunction syndrome).